SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-114133
Filing Date
2019-04-23
Accepted
2019-04-23 07:05:32
Documents
6
Effectiveness Date
2019-04-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d732747ddefa14a.htm DEFA14A 39037
2 GRAPHIC g732747g71u90.jpg GRAPHIC 3704
3 GRAPHIC g732747img02.jpg GRAPHIC 1873
4 GRAPHIC g732747img03.jpg GRAPHIC 1869
5 GRAPHIC g732747img04.jpg GRAPHIC 1868
6 GRAPHIC g732747newimg01.jpg GRAPHIC 1868
  Complete submission text file 0001193125-19-114133.txt   56188
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37490 | Film No.: 19760628
SIC: 2834 Pharmaceutical Preparations